• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有或无膀胱过度活动症症状的口干症患病率。

Prevalence of xerostomia with or without overactive bladder symptoms.

作者信息

Ito Kayoko, Inoue Makoto, Nishii Hisae, Matsumoto Tetsuro

机构信息

Oral Rehabilitation, Niigata University Medical and Dental Hospital, Niigata, Japan.

Division of Dysphagia Rehabilitation, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

出版信息

Low Urin Tract Symptoms. 2021 Apr;13(2):224-229. doi: 10.1111/luts.12354. Epub 2020 Oct 8.

DOI:10.1111/luts.12354
PMID:33034141
Abstract

Overactive bladder (OAB) occurs idiopathic or secondary to a neurological cause. In addition, OAB may also occur due to xerostomia, because it causes excessive drinking of water. If xerostomia is one of the causes of OAB, treating xerostomia may be effective. This study aimed to investigate the prevalence of xerostomia with or without overactive bladder symptoms. A web-based questionnaire was administered to investigate the prevalence of xerostomia with or without overactive bladder symptoms. The survey included questions concerning age, gender, medical history, medications, OAB symptoms by the Overactive Bladder Symptom Score (OABSS), and xerostomia by the Dry Mouth Scale (DMS). From the analysis, a total of 21 (13.0%) participants were identified as having OAB. The prevalence of xerostomia was six (28.6%) in the OAB group and 14 (10.0%) in the non-OAB group. OABSS and DMS were significantly higher in the OAB group than in the non-OAB group. Urgency score and urgency incontinence score of OABSS were substantially higher in xerostomia participants than non-xerostomia participants. The adjusted odds ratio of OAB showed DMS total score, xerostomia symptoms, accompanying symptoms, and other symptoms that were all significantly associated with OAB. These results suggested that OAB subjects, even untreated subjects, had xerostomia. It may be beneficial for clinicians to perform dry mouth management in parallel with careful choice pharmacotherapy for the wellness of OAB patients.

摘要

膀胱过度活动症(OAB)可特发性出现,也可继发于神经学病因。此外,OAB也可能因口干症而发生,因为口干症会导致过度饮水。如果口干症是OAB的病因之一,治疗口干症可能会有效果。本研究旨在调查有或无膀胱过度活动症状的口干症患病率。通过网络问卷来调查有或无膀胱过度活动症状的口干症患病率。该调查包括有关年龄、性别、病史、用药情况、采用膀胱过度活动症症状评分(OABSS)评估的OAB症状以及采用口干量表(DMS)评估的口干症等问题。经分析,共有21名(13.0%)参与者被确定患有OAB。OAB组中口干症的患病率为6名(28.6%),非OAB组为14名(10.0%)。OAB组的OABSS和DMS显著高于非OAB组。口干症参与者的OABSS尿急评分和急迫性尿失禁评分显著高于非口干症参与者。OAB的调整优势比显示,DMS总分、口干症症状、伴随症状和其他症状均与OAB显著相关。这些结果表明,OAB患者,即使是未经治疗的患者,也存在口干症。对于临床医生而言,在为OAB患者选择合适药物治疗的同时并行口干管理,可能对患者健康有益。

相似文献

1
Prevalence of xerostomia with or without overactive bladder symptoms.有或无膀胱过度活动症症状的口干症患病率。
Low Urin Tract Symptoms. 2021 Apr;13(2):224-229. doi: 10.1111/luts.12354. Epub 2020 Oct 8.
2
Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.膀胱过度活动症症状评分(OABSS)的土耳其语验证及米拉贝隆治疗反应评估。
Int Urogynecol J. 2019 Dec;30(12):2121-2126. doi: 10.1007/s00192-019-04054-0. Epub 2019 Jul 22.
3
The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.用于评估膀胱过度活动症及索利那新治疗反应的中国膀胱过度活动症症状评分的翻译与验证
J Formos Med Assoc. 2014 Aug;113(8):506-12. doi: 10.1016/j.jfma.2012.07.044. Epub 2012 Oct 16.
4
Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.波兰版膀胱过度活动症症状评分(OABSS)问卷的可靠性:OABSS与尿动力学研究以及UDI-6和IIQ-7问卷的相关性
Int Urogynecol J. 2019 Dec;30(12):2135-2139. doi: 10.1007/s00192-019-04060-2. Epub 2019 Aug 8.
5
Effect of combined solifenacin and aclatonium in preventing dry mouth in patients with overactive bladder.索利那新与阿克托铵联合使用对预防膀胱过度活动症患者口干的效果。
Low Urin Tract Symptoms. 2019 Jan;11(1):56-60. doi: 10.1111/luts.12194. Epub 2017 Oct 1.
6
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.膀胱过度活动症症状评估工具——膀胱过度活动症症状评分
Urology. 2006 Aug;68(2):318-23. doi: 10.1016/j.urology.2006.02.042.
7
[Impact of the SARS-CV-2 virus on the urinary bladder].[严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒对膀胱的影响]
Urologiia. 2023 Mar(1):41-45.
8
A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome.一项前瞻性观察性研究,旨在评估膀胱过度活动症患者口干与索利那新治疗之间的关联。
Int Urol Nephrol. 2015 Feb;47(2):235-42. doi: 10.1007/s11255-014-0892-x. Epub 2014 Dec 11.
9
Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score.基于三种不同的代谢综合征标准和膀胱过度活动症症状评分,在日本人群中,代谢综合征与男性膀胱过度活动症之间的关系。
Urology. 2012 Jun;79(6):1372-8. doi: 10.1016/j.urology.2012.03.006.
10
Prevalence of overactive bladder and its related factors in Japanese patients with diabetes mellitus.日本糖尿病患者膀胱过度活动症的患病率及其相关因素
Endocr J. 2015;62(9):847-54. doi: 10.1507/endocrj.EJ15-0237. Epub 2015 Jul 11.

引用本文的文献

1
Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States.来自AQUA注册研究的见解:美国抗胆碱能药物联合使用情况的回顾性研究。
Ther Adv Urol. 2023 Jan 19;15:17562872221150572. doi: 10.1177/17562872221150572. eCollection 2023 Jan-Dec.